Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03318003 · ClinicalTrials.gov registry record · NA
Auto-PAP Therapy For Improved Fetal Growth
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT03318003 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 43 participants.
The verdict
NCT03318003, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to see whether the presence of night-time breathing disturbances ("sleep-disordered breathing") in pregnant women is related to fetal growth patterns. The hypothesis is that fetal growth slows in the 3rd trimester in women with sleep-disordered breathing. Use of a nighttime breathing therapy called auto-PAP could minimize the slowing in fetal growth.
Interventions
- DEVICE Auto-PAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2020-08-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03318003
The ClinicalTrials.gov registry entry for NCT03318003 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Auto-PAP is the first listed.
NCT03318003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03318003 about?
NCT03318003 is a clinical study titled "Auto-PAP Therapy For Improved Fetal Growth". The purpose of this study is to see whether the presence of night-time breathing disturbances ("sleep-disordered breathing") in pregnant women is related to fetal growth patterns. The hypothesis is that fetal growth slows in the 3rd trimester in women with sleep-disordered breathing. Use of a nightt...
What is the current status of trial NCT03318003?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2017-12-01. Estimated completion is 2020-08-03.
What interventions are being tested in trial NCT03318003?
The interventions under investigation include: Auto-PAP (DEVICE).
Who is sponsoring clinical trial NCT03318003?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.